Advanced approach for antifungal susceptibility and characterization of resistance properties in clinical and environmental isolates of Cryptococcus species complex
作者机构:Department of NeuromicrobiologyNational Institute of Mental Health and Neuro SciencesBangaloreKarnatakaIndia Department of Computational Medicine and BioinformaticsUniversity of MichiganAnn ArborUSA
出 版 物:《Infectious Medicine》 (感染医学(英文))
年 卷 期:2022年第1卷第3期
页 面:147-153页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
基 金:funding to carry out the research(Grant Number:2121130717 Ref no:18-12/2011(ii)EU-V)
主 题:Cryptococcus neoformans/gattii Environmental isolates Clinical isolates Antifungal susceptibility CnAFR1 Amphotericin B resistance
摘 要:Background:Meningitis due to Cryptococcus neoformans/gattii is a fatal infection affecting immunocompromised population *** B(AmB),fluconazole(FLC)and 5-flucytosine are the drugs of choice to treat the *** studied antifungal susceptibility pattern of clinical and environmental cryptococcal species using newer approach and analyze their resistant ***:Eighty clinical(54 *** and 26 ***)and 18 environmental(14 *** and 4 ***)isolates were subjected to antifungal susceptibility testing by automated(VITEK2C)*** inhibitory concentrations(MIC)were analyzed *** DNA of FLC resistant isolates was extracted and amplified to detect presence of CnAFR1 ***:*** showed 1.85%and 21.4%AmB resistance,and 1.85%and 28.5%FLC-resistance,whereas *** showed 25%and 50%FLC-resistance among clinical and environmental isolates *** values were significantly(p0.05)different for the isolates from 2 ***1 gene sequence analysis revealed phylogenetic relationship among the resistant ***:This pioneering study provides an insight into the sensitivity patterns of clinical and environmental cryptococcal isolates from south *** recent emergence of AmB-resistance may transpire as a challenge for the *** the clinical and environmental isolates are phylogenetically evolved from CnAFR1 gene of Filobasidiella neoformans,the resistance is most probably an inherent *** study emphasizes the need for speciation and antifungal susceptibility testing of cryptococcal isolates from clinical sources to institute appropriate antifungal therapy and to reduce the mortality and morbidity.